Sanofi, GSK to provide COVID-19 vaccine to global alliance
Published
Published
The companies are to supply 200 million doses of Covid vaccine to a global scheme.
LONDON (AP) — Drugmakers Sanofi and GlaxoSmithKline have agreed to provide 200 million doses of their potential COVID-19 vaccine..